Analysis of a functional polymorphism in the CTGF/CCN2 promoter in Systemic Sclerosis.
Carla Fonseca, David Abraham(University College London), A Holmes, CP Denton(The Royal Free Hospital), GE Lindahl, SW Xu, Elisabetta Renzoni(Guy's and St Thomas' NHS Foundation Trust)
UCL Discovery (University College London)
September 1, 2005
Cited by 0
Related Papers
Systemic sclerosis: a prototypic multisystem fibrotic disorder
|Journal of Clinical Investigation|2007|1.1k
Diagnosis of Hypersensitivity Pneumonitis in Adults: An Official ATS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2020|1k
Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach
|Annals of the Rheumatic Diseases|2003|769
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
|Annals of the Rheumatic Diseases|2010|503
Connective Tissue Growth Factor Gene Regulation
|Journal of Biological Chemistry|2003|301